The Grant Program from the Gateway for Cancer Research funds early-phase clinical trials for any type of cancer, conducted at renowned research institutions worldwide. Grants are typically 2-5 years in duration with award amounts from 200,000 to 1.5 million USD (no indirect costs). Applicants are required to first submit a letter of intent (LOI). Eligible applicants will be given 4-5 weeks to complete their full application.
The next LOI closing date is December 15, 2023.